Diabetes as a determinant of mortality in cystic fibrosis.
about
A Practical Approach to Glucose Abnormalities in Cystic FibrosisRate of improvement of CF life expectancy exceeds that of general population--observational death registration study.Hyperglycemia and death in cystic fibrosis-related diabetes.Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sexDemographic, clinical, and laboratory parameters of cystic fibrosis during the last two decades: a comparative analysis.Gender differences in outcomes of patients with cystic fibrosisLow glycaemic index dietary interventions in youth with cystic fibrosis: a systematic review and discussion of the clinical implications.Pancreatic pathophysiology in cystic fibrosis.Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions.Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related DiabetesOral glucose tolerance testing in children with cystic fibrosis.Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.A novel gene delivery method transduces porcine pancreatic duct epithelial cells.Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population.Vitamin D bioavailability in cystic fibrosis: a cause for concern?The development of diabetes among Danish cystic fibrosis patients over the last two decades.CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis.Risk factors for development of new-onset diabetes mellitus after transplant in adult lung transplant recipients.Patient and parent perceptions of the diagnosis and management of cystic fibrosis-related diabetes.Pharmacological management of cystic fibrosis related diabetes.Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides.Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trialLow-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study
P2860
Q28067394-50B670B0-2F71-4987-B6F1-253CA74F9BF7Q33818393-DA7D44E9-7E49-43D4-8F29-E0D9804DC62DQ35060271-0ACB284B-7A4C-4D10-B165-523FCDFEBFC4Q35136628-329B1564-BEED-46D6-BDF3-41FA712BB898Q35140718-B85B921F-1555-4942-93D2-A461791C527CQ35543580-99D25BF8-1E02-40F7-A378-9C6DA9B4E7E9Q35641585-61FD57A9-29D4-434C-B9A9-D40C50F18179Q35942597-209EE0CA-738A-4073-842E-6B8525E95F12Q36424575-D1D6BA20-2811-41BE-9090-02E1960C1DAEQ36605683-AA2D95D1-D6FE-4B9A-B815-C1BACF39FCD2Q36658777-B9BD3E05-9C9D-4C82-B768-D6BA22C46E2BQ37239325-C24557C8-DEA5-4401-850F-67C8B9E96C91Q37377703-6F4E69B2-87F9-4BCD-AA78-548C1690E068Q37483419-E7DDEC61-504E-4500-B6C8-947E742E970DQ37624228-E4008A4A-09B1-4CE9-B0C3-AF914746FE9CQ37809636-45B0A838-BF71-4219-8FF8-D8288EC81F37Q38005772-40076D10-346D-408D-970B-A8461AC25305Q38217187-D3678CEE-F354-4269-A79E-15B2CB691E0BQ38656600-BEEE33B9-59B1-4F9D-8CEE-F166E993E0AEQ39570604-B8978687-648C-4A97-8EF7-0903F42CC0F7Q46364896-79068965-BD0B-4AA8-BF64-C2514F5223FFQ47118798-2178949B-89C2-49ED-8F35-A7DACDFEB00EQ47266208-8B3EEB06-5E4A-44D1-9F17-1512DA139EC1Q48358705-255AEEAC-267B-473F-BD50-8FD0319795D8Q54265700-D1192496-2146-41A8-8F65-7993B454D26FQ58025066-4236D811-FC81-4862-818C-DA46C5635F47
P2860
Diabetes as a determinant of mortality in cystic fibrosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Diabetes as a determinant of mortality in cystic fibrosis.
@ast
Diabetes as a determinant of mortality in cystic fibrosis.
@en
type
label
Diabetes as a determinant of mortality in cystic fibrosis.
@ast
Diabetes as a determinant of mortality in cystic fibrosis.
@en
prefLabel
Diabetes as a determinant of mortality in cystic fibrosis.
@ast
Diabetes as a determinant of mortality in cystic fibrosis.
@en
P2093
P2860
P356
P1433
P1476
Diabetes as a determinant of mortality in cystic fibrosis.
@en
P2093
Amanda I Adler
Brian S F Shine
Charles S Haworth
Diana Bilton
P2860
P304
P356
10.2337/DC09-1215
P407
P577
2009-11-16T00:00:00Z